TY - JOUR
T1 - Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3
AU - Thompson, Alexander J.
AU - Patel, Keyur
AU - Chuang, Wan Long
AU - Lawitz, Eric J.
AU - Rodriguez-Torres, Maribel
AU - Rustgi, Vinod K.
AU - Flisiak, Robert
AU - Pianko, Stephen
AU - Diago, Moises
AU - Arora, Sanjeev
AU - Foster, Graham R.
AU - Torbenson, Michael
AU - Benhamou, Yves
AU - Nelson, David R.
AU - Sulkowski, Mark S.
AU - Zeuzem, Stefan
AU - Pulkstenis, Erik
AU - Subramanian, G. Mani
AU - McHutchison, John G.
PY - 2012/1
Y1 - 2012/1
N2 - Objectives: Genotype-specific associations between hepatitis C virus (HCV) and insulin resistance (IR) have been described, but a causal relationship remains unclear. This study investigated the association between a sustained virological response (SVR) and IR after chronic HCV therapy. Methods: 2255 treatment-naive patients with chronic HCV genotype 1 or 2/3 were enrolled in two phase 3 trials of albinterferon alpha-2b versus pegylated interferon alpha-2a for 48 or 24 weeks, respectively. IR was measured before treatment and 12 weeks after treatment using homeostasis model assessment (HOMA)-IR. Results: Paired HOMA-IR measurements were available in 1038 non-diabetic patients (497 with genotype 1; 541 with genotype 2/3). At baseline the prevalence of HOMA-IR >3 was greater in patients with genotype 1 than 2/3 (33% vs 27%; p=0.048). There was a significant reduction in the prevalence of IR in patients with genotype 1 achieving SVR (δ 10%; p<0.001), but not in genotype 1 non-responders or those with genotype 2/3. Multivariate analysis indicated that SVR was associated with a significant reduction in mean HOMA-IR in patients with genotype 1 (p=0.004), but not in those with genotype 2/3, which was independent of body mass index, alanine transaminase, γ-glutamyl transpeptidase and lipid level changes. Conclusions: SVR is associated with a reduction in HOMA-IR in patients with HCV genotype 1 but not in those with genotype 2/3. Genotype 1 may have a direct effect on the development of IR, independent of host metabolic factors, and may be partially reversed by viral eradication.
AB - Objectives: Genotype-specific associations between hepatitis C virus (HCV) and insulin resistance (IR) have been described, but a causal relationship remains unclear. This study investigated the association between a sustained virological response (SVR) and IR after chronic HCV therapy. Methods: 2255 treatment-naive patients with chronic HCV genotype 1 or 2/3 were enrolled in two phase 3 trials of albinterferon alpha-2b versus pegylated interferon alpha-2a for 48 or 24 weeks, respectively. IR was measured before treatment and 12 weeks after treatment using homeostasis model assessment (HOMA)-IR. Results: Paired HOMA-IR measurements were available in 1038 non-diabetic patients (497 with genotype 1; 541 with genotype 2/3). At baseline the prevalence of HOMA-IR >3 was greater in patients with genotype 1 than 2/3 (33% vs 27%; p=0.048). There was a significant reduction in the prevalence of IR in patients with genotype 1 achieving SVR (δ 10%; p<0.001), but not in genotype 1 non-responders or those with genotype 2/3. Multivariate analysis indicated that SVR was associated with a significant reduction in mean HOMA-IR in patients with genotype 1 (p=0.004), but not in those with genotype 2/3, which was independent of body mass index, alanine transaminase, γ-glutamyl transpeptidase and lipid level changes. Conclusions: SVR is associated with a reduction in HOMA-IR in patients with HCV genotype 1 but not in those with genotype 2/3. Genotype 1 may have a direct effect on the development of IR, independent of host metabolic factors, and may be partially reversed by viral eradication.
UR - http://www.scopus.com/inward/record.url?scp=83555177345&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=83555177345&partnerID=8YFLogxK
U2 - 10.1136/gut.2010.236158
DO - 10.1136/gut.2010.236158
M3 - Article
C2 - 21873466
AN - SCOPUS:83555177345
SN - 0017-5749
VL - 61
SP - 128
EP - 134
JO - Gut
JF - Gut
IS - 1
ER -